Bischof + Klein Invests in New Coex Extrusion Line

Article

With this new line, Bischof + Klein will double its extrusion capacities for its CleanFlex clean room films.

Bischof + Klein is investing in a new coex extrusion line, which will double its extrusion capacities for its CleanFlex clean room films. The investment was made to respond to the increasing demand for high-purity packaging for pharmaceuticals and the medical technology industry.

The existing ISO class 5 clean room according to DIN EN ISO 14644 is being extended by a further 460 m² to a total of three levels for this new line. A new 18-m high extruder tower is being integrated into the existing hall specifically for the new machine. The intention is to manufacture both existing product solutions as well as new developments, which have not yet been produced under clean room conditions, on the new machine.

The extension is located away from the current clean room extrusion facilities, resulting in two spatially separated extrusion areas. As part of the company’s risk management strategy, having two separated areas enables production to switch to another extrusion area in the event of malfunctions, thereby, ensuring supply security.

Planning and construction of the clean room were undertaken based on current standards such as DIN EN ISO 14644. Bischof + Klein is implementing online monitoring technology to monitor the clean room parameters to achieve maximum possible process safety and meet customers' increasing requirements. In the future, glass elements in the new area will enable auditors and visitors to take a look into the production department. Qualification and validation of the new production line and the products have been scheduled for spring of 2017.

Source: Bischof + Klein

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content